These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18849018)

  • 1. Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma.
    Brunello A; Saia G; Bedogni A; Scaglione D; Basso U
    Bone; 2009 Jan; 44(1):173-5. PubMed ID: 18849018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications.
    Nicolatou-Galitis O; Migkou M; Psyrri A; Bamias A; Pectasides D; Economopoulos T; Raber-Durlacher JE; Dimitriadis G; Dimopoulos MA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):234-8. PubMed ID: 22669112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
    Bozas G; Roy A; Ramasamy V; Maraveyas A
    Onkologie; 2010; 33(6):321-3. PubMed ID: 20523097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases.
    Hoefert S; Eufinger H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):463-9. PubMed ID: 20692189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.
    Park CY
    Anticancer Drugs; 2009 Oct; 20(9):848-9. PubMed ID: 19644356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteonecrosis of the jaw related to sunitinib.
    Koch FP; Walter C; Hansen T; Jäger E; Wagner W
    Oral Maxillofac Surg; 2011 Mar; 15(1):63-6. PubMed ID: 20401503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteonecrosis of the jaws in patients assuming bisphosphonates and sunitinib: two case reports.
    Agrillo A; Nastro Siniscalchi E; Facchini A; Filiaci F; Ungari C
    Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):952-7. PubMed ID: 22953645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?
    Ayllon J; Launay-Vacher V; Medioni J; Cros C; Spano JP; Oudard S
    Ann Oncol; 2009 Mar; 20(3):600-1. PubMed ID: 19188135
    [No Abstract]   [Full Text] [Related]  

  • 9. Sunitinib related osteonecrosis of jaw: a case report.
    Fleissig Y; Regev E; Lehman H
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Mar; 113(3):e1-3. PubMed ID: 22676833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.
    Vickers MM; Heng DY; Hemmelgarn B; Eigl BJ
    Clin Genitourin Cancer; 2009 Oct; 7(3):E104-6. PubMed ID: 19815480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
    De Vincenzo F; Zucali PA; Ceresoli GL; Colombo P; Simonelli M; Lorenzi E; Perrino M; Gianoncelli L; De Sanctis R; Graziotti P; Santoro A
    J Clin Oncol; 2011 Jun; 29(18):e529-31. PubMed ID: 21483010
    [No Abstract]   [Full Text] [Related]  

  • 12. Metastatic collecting duct carcinoma of the kidney responded to sunitinib.
    Miyake H; Haraguchi T; Takenaka A; Fujisawa M
    Int J Clin Oncol; 2011 Apr; 16(2):153-5. PubMed ID: 20686910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of psoriasis during sunitinib therapy for renal cell carcinoma.
    Narayanan S; Callis-Duffin K; Batten J; Agarwal N
    Am J Med Sci; 2010 Jun; 339(6):580-1. PubMed ID: 20421784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sunitinib-induced acute psychosis: case report.
    Kunene V; Porfiri E
    Clin Genitourin Cancer; 2011 Sep; 9(1):70-2. PubMed ID: 21729680
    [No Abstract]   [Full Text] [Related]  

  • 15. Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy.
    Katta A; Fesler MJ; Tan A; Vuong G; Richart JM
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):409-12. PubMed ID: 20204363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent treatment with sunitinib may achieve complete response in metastatic renal cell carcinoma.
    Aksu G; Ensaroglu F; Dolasik I; Temiz S; Halis H; Sener SY; Kaya A; Uygun K
    J BUON; 2010; 15(4):798-9. PubMed ID: 21229650
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate.
    Nicholaou T; Wong R; Davis ID
    Lancet; 2007 Jun; 369(9577):1923-4. PubMed ID: 17560435
    [No Abstract]   [Full Text] [Related]  

  • 18. Bronchial fistula associated with sunitinib in a patient previously treated with radiation therapy.
    Basille D; Andrejak M; Bentayeb H; Kanaan M; Fournier C; Lecuyer E; Boutemy M; Garidi R; Douadi Y; Dayen C
    Ann Pharmacother; 2010 Feb; 44(2):383-6. PubMed ID: 20118139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sunitinib in patients with metastatic renal cell carcinoma.
    Motzer RJ; Rini BI; Bukowski RM; Curti BD; George DJ; Hudes GR; Redman BG; Margolin KA; Merchan JR; Wilding G; Ginsberg MS; Bacik J; Kim ST; Baum CM; Michaelson MD
    JAMA; 2006 Jun; 295(21):2516-24. PubMed ID: 16757724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe rhabdomyolysis during sunitinib treatment of metastatic renal cell carcinoma. A report of two cases.
    Ruggeri EM; Cecere FL; Moscetti L; Doni L; Padalino D; Di Costanzo F
    Ann Oncol; 2010 Sep; 21(9):1926-1927. PubMed ID: 20729535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.